NOT-RM-23-020: Notice of Correction to modify the label to R&R Budget" for RFA-RM-23-005 "NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)"

Notice of Correction to modify the label to “R&R Budget" for RFA-RM-23-005 "NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)"

Notice Number:

NOT-RM-23-020

Key Dates

Release Date:

July 7, 2023

Related Announcements

March 29, 2023 - NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional). See RFA-RM-23-005

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

This Notice corrects the label to “R&R or Modular Budget” for RFA-RM-23-005 “NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)”.

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Currently, it reads:

Modular Budget

Revised to read (in bold italics):

R&R Budget

All other aspects of RFA-RM-23-005 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Patricia Labosky, Ph.D.
Office of the Director (OD)
Email: NewInnovatorAwards@mail.nih.gov

Peer Review Contact(s)

Center for Scientific Review (CSR)
Email: FOAReviewContact@csr.nih.gov

Financial/Grants Management Contact(s)

Michael Morse
Office of the Director (OD)
Telephone: 301-435-5446
Email: morsem@od.nih.gov